Announcements
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
- CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
- CytoSorbents Reports First Quarter 2024 Results
- CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
- CytoSorbents to Report First Quarter 2024 Operating and Financial Results
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
- CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.36 |
---|---|
High | 9.36 |
Low | 9.36 |
Bid | 8.69 |
Offer | 8.89 |
Previous close | 9.36 |
Average volume | -- |
---|---|
Shares outstanding | 54.31m |
Free float | 52.57m |
P/E (TTM) | -- |
Market cap | 45.68m USD |
EPS (TTM) | -0.5869 USD |
Data delayed at least 15 minutes, as of Jun 09 2020.
More ▼